Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient

to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients Clinical Trial

— PredictCovid19  

Official title:

Bayesian Network to Predict Transfer in Intensive Care Units or Death in Newly Covid-19 Hospitalized Patient

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04412031
• Other study ID #: 20_185
• Status: Completed
• Start date: November 11, 2019
• Est. completion date: May 15, 2020

Study information

• Verified date: May 2020
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The project is a part of the "Protocol for a multicentre study of nosocomial SARS-CoV2 transmission: The NOSO-COR Project" registered in ClinicalTrials (NCT04290780).

In the current pandemic context, medical resources have often been exceeded. Developing, using artificial intelligence techniques, an algorithm capable of detecting patients at risk of acute respiratory distress following Sars-Cov2 infection could help physicians to optimize the treatment of patients and health decision-makers to optimize resources. Thus, the goal of this project is to create a prediction model using artificial intelligence to predict an unfavorable evolution of Covid-19 at the hospital admission of patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 802
• Est. completion date: May 15, 2020
• Est. primary completion date: May 14, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant must be 18 years or older at the time of signing the informed consent

• Volunteer patients, care givers and healthcare professionals in France and hospitals affiliated with the GABRIEL network. Demographic and clinical data will be collected using case-report forms designed especially for the purpose of the project.

• A nasopharyngeal swab will be collected and tested for SARS-CoV2 by RT-PCR.

• Admission to hospital

Exclusion Criteria:

• Age lower than 18 years old

• Patients protected by the law

Related Conditions & MeSH terms

• to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients

Intervention

Other:
• non applicable
non applicable

Locations

Country	Name	City	State
France	Hôpital E Herriot - Hospices Civils de LYON	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Need of mechanical ventilation, transfer to an intensive care unit or death within 21 days of admission.		within 21 days